ARTICLE | Clinical News
FluMist intranasal influenza vaccine regulatory update
January 2, 2001 8:00 AM UTC
The FDA accepted AVIR's BLA for FluMist to prevent influenza in healthy children and adults, triggering a $15.5 million payment to AVIR from partner American Home Porducts Corp. (AHP, Madison, N.J.). ...